CLINICAL TRIALS PROFILE FOR OBILTOXAXIMAB
✉ Email this page to a colleague
All Clinical Trials for obiltoxaximab
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01952444 ↗ | Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers | Completed | Elusys Therapeutics | Phase 1 | 2013-10-29 | Evaluate the safety, tolerability and pharmacokinetics (PK) of intravenous (IV) ETI-204 alone and in the presence of IV and oral ciprofloxacin |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for obiltoxaximab
Condition Name
Clinical Trial Locations for obiltoxaximab
Trials by Country
Clinical Trial Progress for obiltoxaximab
Clinical Trial Phase
Clinical Trial Sponsors for obiltoxaximab
Sponsor Name